Spatial Distribution and Burden of Emerging Arboviruses in French Guiana.
Adolescent
Adult
Aged
Antibodies, Viral
/ blood
Arbovirus Infections
/ classification
Arboviruses
/ classification
Child
Child, Preschool
Cost of Illness
Cross-Sectional Studies
Demography
Female
French Guiana
/ epidemiology
Humans
Immunoglobulin G
/ blood
Male
Middle Aged
Prevalence
Seroepidemiologic Studies
Young Adult
Chikungunya
Dengue
French Guiana
Mayaro
Zika
arboviruses
prevalence studies
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
02 07 2021
02 07 2021
Historique:
received:
08
06
2021
revised:
25
06
2021
accepted:
29
06
2021
entrez:
10
8
2021
pubmed:
11
8
2021
medline:
15
12
2021
Statut:
epublish
Résumé
Despite the health, social and economic impact of arboviruses in French Guiana, very little is known about the extent to which infection burden is shared between individuals. We conducted a large multiplexed serological survey among 2697 individuals from June to October 2017. All serum samples were tested for IgG antibodies against DENV, CHIKV, ZIKV and MAYV using a recombinant antigen-based microsphere immunoassay with a subset further evaluated through anti-ZIKV microneutralization tests. The overall DENV seroprevalence was estimated at 73.1% (70.6-75.4) in the whole territory with estimations by serotype at 68.9% for DENV-1, 38.8% for DENV-2, 42.3% for DENV-3, and 56.1% for DENV-4. The overall seroprevalence of CHIKV, ZIKV and MAYV antibodies was 20.3% (17.7-23.1), 23.3% (20.9-25.9) and 3.3% (2.7-4.1), respectively. We provide a consistent overview of the burden of emerging arboviruses in French Guiana, with useful findings for risk mapping, future prevention and control programs. The majority of the population remains susceptible to CHIKV and ZIKV, which could potentially facilitate the risk of further re-emergences. Our results underscore the need to strengthen MAYV surveillance in order to rapidly detect any substantial changes in MAYV circulation patterns.
Identifiants
pubmed: 34372505
pii: v13071299
doi: 10.3390/v13071299
pmc: PMC8310293
pii:
doi:
Substances chimiques
Antibodies, Viral
0
Immunoglobulin G
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Bull Pan Am Health Organ. 1995 Jun;29(2):147-55
pubmed: 7640693
J Clin Virol. 2016 Apr;77:66-8
pubmed: 26921736
PLoS Negl Trop Dis. 2016 Apr 29;10(4):e0004681
pubmed: 27128312
Euro Surveill. 2017 Nov;22(44):
pubmed: 29113627
Am J Trop Med Hyg. 1998 Sep;59(3):452-6
pubmed: 9749643
PLoS One. 2017 Feb 14;12(2):e0172267
pubmed: 28196111
Biomed Res Int. 2015;2015:678084
pubmed: 26457301
Med Clin North Am. 2008 Nov;92(6):1377-90, x
pubmed: 19061757
Bull Soc Pathol Exot. 1996;89(2):98-100; discussion 101
pubmed: 8924782
Nat Commun. 2020 Jun 5;11(1):2842
pubmed: 32503971
PLoS Pathog. 2014 Oct 02;10(10):e1004386
pubmed: 25275316
Rev Panam Salud Publica. 2006 Dec;20(6):407-15
pubmed: 17341332
Bull Soc Pathol Exot. 1996;89(2):115-9
pubmed: 8924768
J Infect Dis. 2019 Nov 6;220(12):1915-1925
pubmed: 31418012
PLoS Negl Trop Dis. 2015 Nov 20;9(11):e0004226
pubmed: 26588076
PLoS Negl Trop Dis. 2014 Nov 06;8(11):e3235
pubmed: 25375627
Am J Trop Med Hyg. 2017 Aug;97(2):344-355
pubmed: 28722640
J Am Med Inform Assoc. 2014 Oct;21(e2):e232-40
pubmed: 24549761
Stud Health Technol Inform. 2011;169:629-33
pubmed: 21893824
mBio. 2016 Oct 11;7(5):
pubmed: 27729507
Nature. 2013 Apr 25;496(7446):504-7
pubmed: 23563266
PLoS Negl Trop Dis. 2020 Mar 24;14(3):e0008193
pubmed: 32208419
Am J Trop Med Hyg. 2010 Jan;82(1):128-35
pubmed: 20065008
Antiviral Res. 2010 Aug;87(2):111-24
pubmed: 19616028
BMJ Glob Health. 2018 Jan 4;3(Suppl 1):e000530
pubmed: 29435366
Am J Trop Med Hyg. 1994 Nov;51(5):545-53
pubmed: 7985746
Trop Med Health. 2011 Dec;39(4 Suppl):3-11
pubmed: 22500131
Am J Trop Med Hyg. 2012 Oct;87(4):584-93
pubmed: 23042846
Expert Rev Vaccines. 2011 May;10(5):563-5
pubmed: 21604976
PLoS Negl Trop Dis. 2016 Nov 1;10(11):e0005081
pubmed: 27802275
Mem Inst Oswaldo Cruz. 2018 Mar 12;113(5):e170398
pubmed: 29538490
Lancet. 2016 Apr 9;387(10027):1531-1539
pubmed: 26948433
Nat Microbiol. 2019 May;4(5):854-863
pubmed: 30833735
One Health. 2017 Jul 01;4:1-13
pubmed: 28785601
PLoS Negl Trop Dis. 2018 Jul 16;12(7):e0006533
pubmed: 30011271
Elife. 2019 Apr 08;8:
pubmed: 30958263
Nature. 2018 May;557(7707):719-723
pubmed: 29795354